- Home
- IRMD vs DLY Comparison
IRMD vs DLY Comparison
Compare IRMD & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRMD
- DLY
- Stock Information
- Founded
- IRMD 1992
- DLY 2019
- Country
- IRMD United States
- DLY United States
- Employees
- IRMD 160
- DLY N/A
- Industry
- IRMD Medical/Dental Instruments
- DLY Investment Managers
- Sector
- IRMD Health Care
- DLY Finance
- Exchange
- IRMD Nasdaq
- DLY Nasdaq
- Market Cap
- IRMD 668.2M
- DLY 703.9M
- IPO Year
- IRMD 2014
- DLY N/A
- Fundamental
- Price
- IRMD $57.99
- DLY $15.65
- Analyst Decision
- IRMD Strong Buy
- DLY
- Analyst Count
- IRMD 1
- DLY 0
- Target Price
- IRMD $72.00
- DLY N/A
- AVG Volume (30 Days)
- IRMD 34.7K
- DLY 215.9K
- Earning Date
- IRMD 05-05-2025
- DLY 01-01-0001
- Dividend Yield
- IRMD 1.18%
- DLY 8.93%
- EPS Growth
- IRMD 10.72
- DLY N/A
- EPS
- IRMD 1.55
- DLY N/A
- Revenue
- IRMD $75,154,639.00
- DLY N/A
- Revenue This Year
- IRMD $10.62
- DLY N/A
- Revenue Next Year
- IRMD $9.69
- DLY N/A
- P/E Ratio
- IRMD $37.35
- DLY N/A
- Revenue Growth
- IRMD 11.04
- DLY N/A
- 52 Week Low
- IRMD $41.69
- DLY $13.26
- 52 Week High
- IRMD $63.29
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- IRMD 64.00
- DLY 62.97
- Support Level
- IRMD $50.88
- DLY $15.30
- Resistance Level
- IRMD $59.05
- DLY $15.59
- Average True Range (ATR)
- IRMD 1.90
- DLY 0.15
- MACD
- IRMD 0.57
- DLY 0.03
- Stochastic Oscillator
- IRMD 83.54
- DLY 86.17
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.